{"id":"https://openalex.org/W4367397355","doi":"https://doi.org/10.1016/j.jphs.2023.04.009","title":"Platinum-based anticancer drugs-induced downregulation of myosin heavy chain isoforms in skeletal muscle of mouse","display_name":"Platinum-based anticancer drugs-induced downregulation of myosin heavy chain isoforms in skeletal muscle of mouse","alternate_titles":[],"publication_year":2023,"publication_date":"2023-04-29","ids":{"openalex":"https://openalex.org/W4367397355","doi":"https://doi.org/10.1016/j.jphs.2023.04.009","pmid":"https://pubmed.ncbi.nlm.nih.gov/37257944"},"language":"en","primary_location":{"id":"doi:10.1016/j.jphs.2023.04.009","doi":"https://doi.org/10.1016/j.jphs.2023.04.009","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jphs.2023.04.009","pdf_url":null,"source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4367397355"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.jphs.2023.04.009","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102482552","display_name":"Ken Sato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36296616","display_name":"Hoshi University","ror":"https://ror.org/01mrvbd33","country_code":"JP","type":"education","lineage":["https://openalex.org/I36296616"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ken Sato","raw_affiliation_strings":["Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan","institution_ids":["https://openalex.org/I36296616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036786013","display_name":"Yu Miyauchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36296616","display_name":"Hoshi University","ror":"https://ror.org/01mrvbd33","country_code":"JP","type":"education","lineage":["https://openalex.org/I36296616"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yu Miyauchi","raw_affiliation_strings":["Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan","institution_ids":["https://openalex.org/I36296616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103896719","display_name":"Xinran Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36296616","display_name":"Hoshi University","ror":"https://ror.org/01mrvbd33","country_code":"JP","type":"education","lineage":["https://openalex.org/I36296616"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Xinran Xu","raw_affiliation_strings":["Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan","institution_ids":["https://openalex.org/I36296616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030093124","display_name":"Risako Kon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36296616","display_name":"Hoshi University","ror":"https://ror.org/01mrvbd33","country_code":"JP","type":"education","lineage":["https://openalex.org/I36296616"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Risako Kon","raw_affiliation_strings":["Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan","institution_ids":["https://openalex.org/I36296616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048802605","display_name":"Nobutomo Ikarashi","orcid":"https://orcid.org/0000-0001-6991-2946","observed_orcids":["https://orcid.org/0000-0001-6991-2946"]},"institutions":[{"id":"https://openalex.org/I36296616","display_name":"Hoshi University","ror":"https://ror.org/01mrvbd33","country_code":"JP","type":"education","lineage":["https://openalex.org/I36296616"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Nobutomo Ikarashi","raw_affiliation_strings":["Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan","institution_ids":["https://openalex.org/I36296616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058666311","display_name":"Yoshihiko Chiba","orcid":"https://orcid.org/0000-0002-7342-4491","observed_orcids":["https://orcid.org/0000-0002-7342-4491"]},"institutions":[{"id":"https://openalex.org/I36296616","display_name":"Hoshi University","ror":"https://ror.org/01mrvbd33","country_code":"JP","type":"education","lineage":["https://openalex.org/I36296616"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshihiko Chiba","raw_affiliation_strings":["Department of Physiology and Molecular Sciences, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physiology and Molecular Sciences, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan","institution_ids":["https://openalex.org/I36296616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048646943","display_name":"Tomoo Hosoe","orcid":"https://orcid.org/0000-0002-0877-6263","observed_orcids":["https://orcid.org/0000-0002-0877-6263"]},"institutions":[{"id":"https://openalex.org/I36296616","display_name":"Hoshi University","ror":"https://ror.org/01mrvbd33","country_code":"JP","type":"education","lineage":["https://openalex.org/I36296616"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoo Hosoe","raw_affiliation_strings":["Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan; Department of Bioregulatory Science, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan","Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan","Department of Bioregulatory Science, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan; Department of Bioregulatory Science, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan","institution_ids":["https://openalex.org/I36296616"]},{"raw_affiliation_string":"Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan","institution_ids":["https://openalex.org/I36296616"]},{"raw_affiliation_string":"Department of Bioregulatory Science, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan","institution_ids":["https://openalex.org/I36296616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004477338","display_name":"Hiroyasu Sakai","orcid":"https://orcid.org/0000-0002-4501-2836","observed_orcids":["https://orcid.org/0000-0002-4501-2836"]},"institutions":[{"id":"https://openalex.org/I36296616","display_name":"Hoshi University","ror":"https://ror.org/01mrvbd33","country_code":"JP","type":"education","lineage":["https://openalex.org/I36296616"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Hiroyasu Sakai","raw_affiliation_strings":["Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan. Electronic address: sakai@hoshi.ac.jp","Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan"],"raw_orcid":"https://orcid.org/0000-0002-4501-2836","affiliations":[{"raw_affiliation_string":"Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan. Electronic address: sakai@hoshi.ac.jp","institution_ids":["https://openalex.org/I36296616"]},{"raw_affiliation_string":"Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 1428501, Japan","institution_ids":["https://openalex.org/I36296616"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5004477338"],"corresponding_institution_ids":["https://openalex.org/I36296616"],"apc_list":{"value":2070,"currency":"USD","value_usd":2070},"apc_paid":{"value":2070,"currency":"USD","value_usd":2070},"fwci":0.4313,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.47425554,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"152","issue":"3","first_page":"167","last_page":"177"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10441","display_name":"Muscle Physiology and Disorders","score":0.8974999785423279,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10441","display_name":"Muscle Physiology and Disorders","score":0.8974999785423279,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10397","display_name":"Nutrition and Health in Aging","score":0.0934000015258789,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11399","display_name":"Muscle metabolism and nutrition","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9490000009536743},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/platinum-based-anticancer-drugs","display_name":"platinum anticancer drugs","score":0.9879999756813049},{"id":"https://openalex.org/keywords/skeletal-muscle-atrophy","display_name":"skeletal muscle atrophy","score":0.8709999918937683},{"id":"https://openalex.org/keywords/myosin-heavy-chain-isoforms","display_name":"myosin heavy chain isoforms","score":0.9900000095367432},{"id":"https://openalex.org/keywords/myh2","display_name":"MYH2","score":0.8149999976158142},{"id":"https://openalex.org/keywords/mef2c","display_name":"MEF2C","score":0.8370000123977661},{"id":"https://openalex.org/keywords/proteasomal-degradation","display_name":"proteasomal degradation","score":0.800000011920929},{"id":"https://openalex.org/keywords/mg132","display_name":"MG132","score":0.9390000104904175},{"id":"https://openalex.org/keywords/c2c12-myotubes","display_name":"C2C12 myotubes","score":0.9390000104904175},{"id":"https://openalex.org/keywords/muscle-strength","display_name":"muscle strength","score":0.7699999809265137}],"concepts":[{"id":"https://openalex.org/C2779959927","wikidata":"https://www.wikidata.org/wiki/Q1048687","display_name":"Skeletal muscle","level":2,"score":0.7687119841575623},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.7501581311225891},{"id":"https://openalex.org/C6997183","wikidata":"https://www.wikidata.org/wiki/Q271727","display_name":"Myosin","level":2,"score":0.7445439100265503},{"id":"https://openalex.org/C2776263037","wikidata":"https://www.wikidata.org/wiki/Q1557686","display_name":"Muscle atrophy","level":3,"score":0.7358018159866333},{"id":"https://openalex.org/C3763915","wikidata":"https://www.wikidata.org/wiki/Q3331437","display_name":"Myogenesis","level":3,"score":0.7339720726013184},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.6487299799919128},{"id":"https://openalex.org/C60278653","wikidata":"https://www.wikidata.org/wiki/Q5008075","display_name":"C2C12","level":4,"score":0.5662169456481934},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5427466034889221},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4722903370857239},{"id":"https://openalex.org/C207200792","wikidata":"https://www.wikidata.org/wiki/Q428914","display_name":"Myocyte","level":2,"score":0.45848792791366577},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3878094255924225},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3350422978401184},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.32207876443862915},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2608966827392578},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24612754583358765},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.08195257186889648},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077150","descriptor_name":"Oxaliplatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001284","descriptor_name":"Atrophy","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010984","descriptor_name":"Platinum","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015536","descriptor_name":"Down-Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018482","descriptor_name":"Muscle, Skeletal","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018485","descriptor_name":"Muscle Fibers, Skeletal","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018995","descriptor_name":"Myosin Heavy Chains","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D018995","descriptor_name":"Myosin Heavy Chains","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020033","descriptor_name":"Protein Isoforms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D020033","descriptor_name":"Protein Isoforms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.jphs.2023.04.009","doi":"https://doi.org/10.1016/j.jphs.2023.04.009","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jphs.2023.04.009","pdf_url":null,"source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},{"id":"pmid:37257944","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37257944","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmacological sciences","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:e1546edfafe64459b2b340fe15163c8e","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/e1546edfafe64459b2b340fe15163c8e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Pharmacological Sciences, Vol 152, Iss 3, Pp 167-177 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.jphs.2023.04.009","doi":"https://doi.org/10.1016/j.jphs.2023.04.009","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jphs.2023.04.009","pdf_url":null,"source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7590988572","display_name":"Comprehensive analysis of cisplatin-induced muscle atrophy mediated by miR-29-3p upregulation","funder_award_id":"22K06869","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320327868","display_name":"Hoshi University","ror":"https://ror.org/01mrvbd33"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W1488497469","https://openalex.org/W1549539116","https://openalex.org/W1551504949","https://openalex.org/W1598386072","https://openalex.org/W1880398352","https://openalex.org/W1967924815","https://openalex.org/W1992427679","https://openalex.org/W2020950228","https://openalex.org/W2037605387","https://openalex.org/W2038806256","https://openalex.org/W2061929833","https://openalex.org/W2063443397","https://openalex.org/W2073131323","https://openalex.org/W2094875155","https://openalex.org/W2100688137","https://openalex.org/W2116631863","https://openalex.org/W2144203293","https://openalex.org/W2152862580","https://openalex.org/W2167033587","https://openalex.org/W2173990401","https://openalex.org/W2741017313","https://openalex.org/W2803324468","https://openalex.org/W2888727362","https://openalex.org/W2999257419","https://openalex.org/W3010539221","https://openalex.org/W3037744716","https://openalex.org/W3045689620","https://openalex.org/W3092786751","https://openalex.org/W3096521890","https://openalex.org/W3127908418","https://openalex.org/W3151502832","https://openalex.org/W3182300906","https://openalex.org/W4220731137","https://openalex.org/W4283765436","https://openalex.org/W4293230540","https://openalex.org/W4293353538","https://openalex.org/W4296860008","https://openalex.org/W6809574939"],"related_works":["https://openalex.org/W4313200295","https://openalex.org/W4283765436","https://openalex.org/W2152862580","https://openalex.org/W4293353538","https://openalex.org/W2023192758","https://openalex.org/W4410695639","https://openalex.org/W4377942320","https://openalex.org/W7166729899","https://openalex.org/W2741017313","https://openalex.org/W2843717716"],"abstract_inverted_index":{"Cisplatin,":[0],"a":[1,33,181],"platinum-based":[2,34,72,96,113,126,169,193],"anticancer":[3,35,73,97,114,127,170,194],"drug":[4,36,74,98],"used":[5],"frequently":[6],"in":[7,94,106,160,188,192],"cancer":[8],"treatment,":[9],"causes":[10],"skeletal":[11,45,107,162,174],"muscle":[12,79,108,163,175,189,196],"atrophy.":[13,28,197],"It":[14],"was":[15,116,151,158],"predicted":[16,152],"that":[17,183],"the":[18,24,38,41,83,95,130,139,161],"proteolytic":[19],"pathway":[20],"is":[21],"enhanced":[22],"as":[23],"mechanism":[25],"of":[26,40,44,71,88,109,122,133,148,156,164,173],"this":[27,144],"Therefore,":[29],"we":[30],"investigated":[31],"whether":[32],"affects":[37],"expression":[39,105,147],"major":[42],"proteins":[43],"muscle,":[46],"myosin":[47],"heavy":[48],"chain":[49],"(MyHC).":[50],"Mice":[51],"were":[52,64,92],"injected":[53],"with":[54,112,125,138,168],"cisplatin":[55,67],"or":[56],"oxaliplatin":[57],"for":[58],"four":[59],"consecutive":[60],"days.":[61],"C2C12":[62,123],"myotubes":[63,124],"treated":[65,111,166],"using":[66],"and":[68,78,136],"oxaliplatin.":[69],"Administration":[70],"reduced":[75,93,129,159],"quadriceps":[76],"mass":[77,190],"strength":[80],"compared":[81],"to":[82,118,153],"control":[84],"group.":[85],"Protein":[86],"levels":[87,132],"all":[89,134],"MyHC":[90],"isoforms":[91],"groups.":[99],"However,":[100],"only":[101],"Myh2":[102],"(MyHC-IIa)":[103],"gene":[104],"mice":[110,165],"drugs":[115,128],"found":[117],"be":[119,180],"reduced.":[120],"Treatment":[121],"protein":[131],"MyHCs,":[135],"treatment":[137],"proteasome":[140],"inhibitor":[141],"MG-132":[142],"restored":[143],"reduction.":[145],"The":[146],"Mef2c,":[149],"which":[150],"act":[154],"upstream":[155],"Myh2,":[157],"systemically":[167],"drug.":[171],"Degradation":[172],"MyHCs":[176],"by":[177],"proteasomes":[178],"may":[179],"factor":[182],"plays":[184],"an":[185],"important":[186],"role":[187],"loss":[191],"drug-induced":[195]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4367397355","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2023-04-30T00:00:00"}
